Home/Filings/4/0001562180-23-003040
4//SEC Filing

Abraham Silji 4

Accession 0001562180-23-003040

CIK 0000105770other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:41 PM ET

Size

9.8 KB

Accession

0001562180-23-003040

Insider Transaction Report

Form 4
Period: 2023-03-01
Abraham Silji
Chief Digital & Trans Officer
Transactions
  • Sale

    Common Stock

    2023-03-09$322.57/sh1,500$483,8504,209.3 total
  • Award

    Common Stock

    2023-03-01$318.28/sh+234$74,4785,709.3 total
Footnotes (2)
  • [F1]Vesting of Bonus & Incentive Grant
  • [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $322.50 to $323.00, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001733001

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:41 PM ET
Size
9.8 KB